Family Medicine · Cleveland, MS
NPI
1689761280
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
810 E Sunflower Rd
Cleveland, MS, 38732
Phone (662) 843-3606
Groups this clinician bills Medicare through
Medicare paid, 2024
$526K
32,775 services
Medicare patients, 2024
993
Average age 73
Drug cost, 2024
$4.2M
32,885 prescriptions
Company payments, 2025
$563
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles E Brock Jr. was code J1010 (injection, methylprednisolone acetate, 1 mg), 9,521 times for 87 patients. In total Charles E Brock Jr. billed 32,775 services in 157 codes, and Medicare paid $526K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 9,521 | 87 | $0.10 | $944 |
| J0897 Injection, denosumab, 1 mg | Office | 4,981 | 56 | $20.55 | $102K |
| 99214 Office E&M - Established | Office | 1,485 | 576 | $74.98 | $111K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,032 | 82 | $0.08 | $86.41 |
| 85025 Blood Count | Office | 833 | 530 | $7.54 | $6,281 |
| 80053 Clinical Chemistry | Office | 793 | 533 | $10.28 | $8,155 |
| 84443 Clinical Chemistry | Office | 703 | 513 | $16.46 | $12K |
| 80061 Clinical Chemistry | Office | 703 | 526 | $12.96 | $9,110 |
| 81003 Clinical Chemistry | Office | 668 | 441 | $2.19 | $1,460 |
| 82607 Clinical Chemistry | Office | 662 | 508 | $14.61 | $9,670 |
| 99233 Hospital E&M - Subsequent | Facility | 657 | 267 | $85.87 | $56K |
| 83036 Blood Count | Office | 650 | 482 | $9.39 | $6,104 |
| 82306 Clinical Chemistry | Office | 479 | 366 | $28.77 | $14K |
| 82044 Clinical Chemistry | Office | 397 | 312 | $6.06 | $2,405 |
| 96372 Injection Administration | Office | 385 | 167 | $9.01 | $3,469 |
By year: 2022 $611K for 39,337 services; 2023 $528K for 39,491 services; 2024 $526K for 32,775 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 833 | 530 | $7.54 | $6,281 |
| 80053 Clinical Chemistry | 793 | 533 | $10.28 | $8,155 |
| 84443 Clinical Chemistry | 703 | 513 | $16.46 | $12K |
| 80061 Clinical Chemistry | 703 | 526 | $12.96 | $9,110 |
| 81003 Clinical Chemistry | 668 | 441 | $2.19 | $1,460 |
| 82607 Clinical Chemistry | 662 | 508 | $14.61 | $9,670 |
| 83036 Blood Count | 650 | 482 | $9.39 | $6,104 |
| 82306 Clinical Chemistry | 479 | 366 | $28.77 | $14K |
| 82044 Clinical Chemistry | 397 | 312 | $6.06 | $2,405 |
| 80305 Drug Tests | 168 | 102 | $12.35 | $2,075 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles E Brock Jr. prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,032 prescriptions and refills. In total Charles E Brock Jr. wrote 32,885 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,032 | 2,606 | 293 | $10K |
| Levothyroxine Sodium Generic | 1,010 | 2,043 | 218 | $7,882 |
| Atorvastatin Calcium Generic | 867 | 2,012 | 227 | $7,282 |
| Potassium Chloride Generic | 739 | 1,382 | 183 | $12K |
| Metoprolol Succinate Generic | 725 | 1,583 | 185 | $7,395 |
| Amlodipine Besylate Generic | 694 | 1,481 | 185 | $4,380 |
| Furosemide Generic | 693 | 1,265 | 186 | $3,089 |
| Gabapentin Generic | 678 | 891 | 150 | $7,003 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 660 | 660 | 122 | $11K |
| Farxiga Dapagliflozin Propanediol | 618 | 927 | 124 | $508K |
| Omeprazole Generic | 541 | 1,244 | 157 | $5,794 |
| Pantoprazole Sodium Generic | 532 | 1,038 | 143 | $7,041 |
| Diclofenac Sodium Generic | 519 | 652 | 153 | $6,802 |
| Eliquis Apixaban | 465 | 574 | 87 | $313K |
| Metformin Hcl Er Metformin Hcl | 447 | 1,063 | 127 | $1,847 |
Brand drugs: 6,173 claims; generic drugs: 26,506 claims; opioid claims: 1,237.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles E Brock Jr. $563 ($563 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $189.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $189 |
| Lilly USA, LLC LLY | 3 | $60.6 |
| Novo Nordisk Inc NVO | 3 | $48.79 |
| Dexcom, Inc. DXCM | 2 | $38.37 |
| Pfizer Inc. PFE | 2 | $34.68 |
| Abbvie Inc. ABBV | 2 | $34.63 |
| Astellas Pharma US Inc 4503.T | 2 | $34.27 |
| Lundbeck LLC | 1 | $33.78 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $31.04 |
| Sanofi Pasteur Inc. SNY | 1 | $23.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.